Company news_innoModel-Provide preclinical pharmacological services

Cn /En

News Center

——

Company news

Industry news

01-17

InnoModels Biotechnology: Introduction to CDX Technology

InnoModels Biotechnology is committed to advancing innovation in biomedical research and clinical therapeutics, and its CDX (Cancer-Derived Xenograft) technology is a leader in the field of cancer modeling. the uniqueness and excellence of CDX technology provides powerful support for cancer research, drug discovery, and personalized therapy

01-17

InnoModels Biotechnology: iHuPDX

InnoModels Biotechnology is committed to advancing innovation in the biomedical field, and its iHuPDX (Individualized Human Patient-Derived Xenograft) technology is an outstanding example of the company's commitment to personalized medicine. iHuPDX technology brings a new perspective to cancer research and treatment, providing more precise and personalized solutions for medical research and drug development. The introduction of iHuPDX technology brings a new perspective to cancer research and treatment, and provides a more precise and personalized solution for medical research and drug development.

01-16

InnoModels Biotechnology: In Situ Surgical Models

InnoModels Biotechnology has been driving innovation in the biomedical field, and its pioneering in-situ surgical modeling technology is opening up new possibilities for medical training and surgical skill enhancement. This technology is expected to lead the way in the field of surgical training by simulating real surgical environments and providing a highly realistic training platform for medical professionals

01-16

InnoModels Biotechnology: Brain In Situ Modeling

InnoModels Biotechnology is committed to driving innovation in biomedical research, and its pioneering in situ brain modeling technology is attracting widespread attention in the scientific community. This technology opens up new possibilities in the field of neuroscience, providing a platform for more realistic and sophisticated research that is expected to deepen our understanding of brain function and disease

< 1...52 53 54...61 >

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License